| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,377 | 4,163 | 25,955 | 45,903 | | Cost of Revenue | 1,759 | 3,699 | 3,775 | 8,277 | | | Gross Profit | 3,618 | 464 | 22,180 | 37,626 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,674 | 2,941 | 3,152 | (1,787) | | Non Recurring |
-
|
-
| 63,818 | 58,887 | | Others | 1,998 | 3,919 | 3,783 | 4,569 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,054) | (6,396) | (48,573) | (24,043) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,797 | 607 | (379) | 13,062 | | Earnings Before Interest And Taxes | 1,743 | (5,789) | (48,952) | (10,981) | | Interest Expense | 1,042 | 979 | 1,013 | 1,628 | | Income Before Tax | 701 | (6,768) | (49,965) | (12,609) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 701 | (6,768) | (49,965) | (12,609) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 701 | (6,768) | (49,965) | (12,609) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $701 | ($6,768) | ($49,965) | ($12,609) |
|
0.20% Nasdaq 
Income Statement
